Lifeng Liu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 6
- Cancer, Hypoxia, and Metabolism 6
- Molecular Biology top 10%
- Fibroblast Growth Factor Research 8
- RNA modifications and cancer 5
- Circular RNAs in diseases 5
- Histone Deacetylase Inhibitors Research 4
- Kruppel-like factors research 4
- Hepatology top 10%
- Co-authors
- Tsung‐Hui HuChao‐Cheng HuangXinhan ZhaoTianjie QinJiin‐Haur ChuangLei HouFeng LuMing‐Hong Tai
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Lifeng Liu
46 papers receiving 959 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 323
- Molecular Biology 708
- Hepatology 63
- Oncology 169
- Cell Biology 68
Countries citing papers authored by Lifeng Liu
This map shows the geographic impact of Lifeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Liu more than expected).
Fields of papers citing papers by Lifeng Liu
This network shows the impact of papers produced by Lifeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Liu. The network helps show where Lifeng Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lifeng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 24 | |
| 6 | 2020 | 18 | |
| 7 | 2019 | 8 | |
| 8 | 2016 | 48 | |
| 9 | 2016 | 26 | |
| 10 | 2015 | 17 | |
| 11 | 2013 | 27 | |
| 12 | 2013 | 17 | |
| 13 | 2013 | 44 | |
| 14 | 2013 | 61 | |
| 15 | 2012 | 76 | |
| 16 | 2012 | 4 | |
| 17 | 2012 | 6 | |
| 18 | 2011 | 33 | |
| 19 | HDGF overexpression enhances the tumorigenicity of hepatocellular carcinoma | 2008 | 1 |
| 20 | 2004 | 60 |
About Lifeng Liu
Lifeng Liu is a scholar working on Cancer Research, Molecular Biology and Behavioral Neuroscience, having authored 46 papers that have together received 965 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (8 papers), Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (5 papers), Circular RNAs in diseases (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Kruppel-like factors research (4 papers). The work is most often cited by research in Cancer Research (323 citations), Molecular Biology (708 citations) and Hepatology (63 citations). Lifeng Liu has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Tsung‐Hui Hu, Chao‐Cheng Huang, Xinhan Zhao, Tianjie Qin, Jiin‐Haur Chuang, Lei Hou, Feng Lu, Ming‐Hong Tai, Peng Xia and Jian Li. Their work appears in journals such as PLoS ONE, Hepatology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.